Tenax Therapeutics TENX
NASDAQ TENX
$1.90 +0.01 (+0.53%)
As of: Oct 1, 2026 · 9:51 AM EDT

Tenax Therapeutics (TENX) Revenue (2010 - 2013)

Updated

Tenax Therapeutics' Revenue was $49,286 in FY2015, down 69.0% from $158,926 in FY2014.

Analysis

Tenax Therapeutics (TENX) Revenue (2010 - 2013) Analysis & Trends

From FY2011 onward, Tenax Therapeutics has reported Revenue for 5 years.

  • Revenue shows a four-year compound annual growth rate of -16.9% (FY2011 to FY2015).
  • The FY2015 figure marks the lowest annual Revenue in data going back to FY2011.
  • Per Business Quant data, Revenue in earlier years was $158,926 in FY2014 (-86.7%), $1.19 million in FY2013 (+227.4%), $363,781 in FY2012 (+252.6%) and $103,167 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Tenax Therapeutics 85.48 Mn 85.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2013 181,572.00
Jan 31, 2013 222,388.00
Oct 31, 2012 514,872.00
Jul 31, 2012 272,096.00
Apr 30, 2012 95,487.00
Jan 31, 2012 148,262.00
Oct 31, 2011 95,159.00
Jul 31, 2011 24,873.00
Apr 30, 2011 44,342.00
Jan 31, 2011 26,589.00
Oct 31, 2010 27,126.00
API Access

Tenax Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=TENX&period=max&api_key=YOUR_API_KEY